We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
+5.48%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+377.38%
AUM
$1.21B
AUM Growth
+$330M
Cap. Flow
+$275M
Cap. Flow %
22.73%
Top 10 Hldgs %
36.41%
Holding
4,516
New
1,790
Increased
1,264
Reduced
722
Closed
680

Sector Composition

Rank Sector Weight
1 Financials 6.31%
2 Technology 5.59%
3 Industrials 5.06%
4 Consumer Discretionary 3.68%
5 Healthcare 3.45%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EQFN
3726
DELISTED
Equitable Financial Corp.
EQFN
$1K ﹤0.01%
+55
New +$558
ATAXZ
3727
DELISTED
AMERICA FIRST TAX EXEMT INV LP
ATAXZ
$1K ﹤0.01%
+100
New +$1K
PLM
3728
DELISTED
PolyMet Mining Corp.
PLM
$1K ﹤0.01%
70
CWBC
3729
DELISTED
Community West BanCshares
CWBC
$1K ﹤0.01%
49
-146
-75% -$1.5K
AACG
3730
ATA Creativity
AACG
$38.9M
-1
Closed
AAP icon
3731
Advance Auto Parts
AAP
$3.36B
-46
Closed -$4.64K
ABR icon
3732
Arbor Realty Trust
ABR
$963M
-40
Closed
ACAD icon
3733
Acadia Pharmaceuticals
ACAD
$4.39B
-638
Closed -$18K
ACIU icon
3734
AC Immune
ACIU
$226M
-3,045
Closed -$27K
ACM icon
3735
Aecom
ACM
$9.61B
-381
Closed -$12K
ACNT icon
3736
Ascent Industries
ACNT
$140M
-932
Closed -$10K
ACRE
3737
Ares Commercial Real Estate
ACRE
$236M
-500
Closed -$6.55K
ACU icon
3738
Acme United Corp
ACU
$220M
$0 ﹤0.01%
4
-92
-96% -$2.43K
ADAP
3739
DELISTED
Adaptimmune Therapeutics
ADAP
-3,663
Closed -$16K
AEF
3740
abrdn Emerging Markets Equity Income Fund
AEF
$356M
-100
Closed -$1K
AFBI icon
3741
Affinity Bancshares
AFBI
$140M
-448
Closed -$6.47K
AGCO icon
3742
AGCO
AGCO
$7.28B
-100
Closed -$7K
AGIO icon
3743
Agios Pharmaceuticals
AGIO
$1.82B
-180
Closed -$9K
AKO.B icon
3744
Embotelladora Andina Series B
AKO.B
$4.72B
$0 ﹤0.01%
+5
New +$135
ALB icon
3745
Albemarle
ALB
$14B
-686
Closed -$81.6K
ALL icon
3746
Allstate
ALL
$67.6B
-74
Closed -$7K
ALLY icon
3747
Ally Financial
ALLY
$13.4B
-10,455
Closed -$219K
ALT icon
3748
Altimmune
ALT
$583M
-452
Closed -$44K
AMLP icon
3749
Alerian MLP ETF
AMLP
$13B
-680
Closed -$41K
AMSC icon
3750
American Superconductor
AMSC
$1.5B
-10,311
Closed -$48K

Similar funds

Tower Research Capital (TRC)'s Q3 2017 Portfolio in Review

As of Q3 2017, Tower Research Capital (TRC) held 4,516 positions worth $1.21B, up 37% from $881M the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Tower Research Capital (TRC) deployed $275M of net new capital in Q3 2017, opening 1,790 new positions and adding to 1,264 existing holdings. Its largest new stake was iShares Morningstar Mid-Cap ETF: 196,556 shares worth $8.59M.

By sector, the portfolio is most concentrated in Financials at 6.3% of assets, up from 2.1% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was iShares MSCI Emerging Markets ETF, an estimated $60M trimmed.

  • Tower Research Capital (TRC)'s largest Q3 2017 buy was iShares Morningstar Mid-Cap ETF: 196,556 shares worth $8.59M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q3 2017, an estimated $135M increase.
  • Tower Research Capital (TRC)'s biggest Q3 2017 reduction was iShares MSCI Emerging Markets ETF, cutting an estimated $60M.
  • Tower Research Capital (TRC) fully exited State Street Consumer Discretionary Select Sector SPDR ETF in Q3 2017, selling an estimated $17.2M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 36% of its $1.21B portfolio in Q3 2017.
  • Tower Research Capital (TRC) opened 1,790 new positions and closed 680 in Q3 2017.
  • Tower Research Capital (TRC)'s portfolio value rose 37% quarter-over-quarter to $1.21B.

Based on Tower Research Capital (TRC)'s 13F filing for Q3 2017, filed 14 Nov 2017.